116 related articles for article (PubMed ID: 8686978)
1. Effects of sodium intake on albumin excretion in patients with diabetic nephropathy treated with long-acting calcium antagonists.
Bakris GL; Smith A
Ann Intern Med; 1996 Aug; 125(3):201-4. PubMed ID: 8686978
[TBL] [Abstract][Full Text] [Related]
2. [Calcium channel blocking agents and albuminuria in diabetic and hypertensive patients. A pilot study].
Lamarre-Cliche M; Lambert R; Van Nguyen P; Cusson J; Wistaff R; Larochelle P
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):919-24. PubMed ID: 10989730
[TBL] [Abstract][Full Text] [Related]
3. Effects of dihydropyridine calcium antagonists on albuminuria in patients with diabetes.
Abbott K; Smith A; Bakris GL
J Clin Pharmacol; 1996 Mar; 36(3):274-9. PubMed ID: 8690823
[TBL] [Abstract][Full Text] [Related]
4. Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy.
Andersen H; Hansen PB; Bistrup C; Nielsen F; Henriksen JE; Jensen BL
J Hypertens; 2016 Aug; 34(8):1621-9. PubMed ID: 27214087
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients.
Fioretto P; Frigato F; Velussi M; Riva F; Muollo B; Carraro A; Brocco E; Cipollina MR; Abaterusso C; Trevisan M
Am J Hypertens; 1992 Nov; 5(11):837-46. PubMed ID: 1457087
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of treatment effects with an angiotensin converting enzyme inhibitor--lisinopril and a calcium blocker--nifedipine retard on urinary albumin excretion in patients with non-complicated essential hypertension].
Widecka K; Celibała R; Czekalski S
Pol Arch Med Wewn; 1995 Feb; 93(2):135-42. PubMed ID: 7479231
[TBL] [Abstract][Full Text] [Related]
7. Renoprotective effect of diltiazem in hypertensive type 2 diabetic patients with persistent microalbuminuria despite ACE inhibitor treatment.
Pérez-Maraver M; Carrera MJ; Micaló T; Sahun M; Vinzia C; Soler J; Montanya E
Diabetes Res Clin Pract; 2005 Oct; 70(1):13-9. PubMed ID: 16126118
[TBL] [Abstract][Full Text] [Related]
8. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
[TBL] [Abstract][Full Text] [Related]
9. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
[TBL] [Abstract][Full Text] [Related]
10. Renal long-term effects of calcium antagonist treatment in patients with diabetes mellitus.
Jungmann E; Usadel KH
Clin Investig; 1992 Oct; 70(10):942-8. PubMed ID: 1450619
[TBL] [Abstract][Full Text] [Related]
11. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
[TBL] [Abstract][Full Text] [Related]
12. Effects of low-dose nifedipine on urinary protein excretion rate in patients with renal disease.
Kloke HJ; Wetzels JF; Koene RA; Huysmans FT
Nephrol Dial Transplant; 1998 Mar; 13(3):646-50. PubMed ID: 9550641
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive and anti-albuminuric effects of losartan potassium and felodipine in Chinese elderly hypertensive patients with or without non-insulin-dependent diabetes mellitus.
Chan JC; Critchley JA; Tomlinson B; Chan TY; Cockram CS
Am J Nephrol; 1997; 17(1):72-80. PubMed ID: 9057957
[TBL] [Abstract][Full Text] [Related]
14. Renal protection and antihypertensive drugs: current status.
Salvetti A; Mattei P; Sudano I
Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
[TBL] [Abstract][Full Text] [Related]
15. Long-term renoprotection by perindopril or nifedipine in non-hypertensive patients with Type 2 diabetes and microalbuminuria.
Jerums G; Allen TJ; Campbell DJ; Cooper ME; Gilbert RE; Hammond JJ; O'Brien RC; Raffaele J; Tsalamandris C;
Diabet Med; 2004 Nov; 21(11):1192-9. PubMed ID: 15498085
[TBL] [Abstract][Full Text] [Related]
16. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
[TBL] [Abstract][Full Text] [Related]
17. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
[TBL] [Abstract][Full Text] [Related]
18. Reduced albuminuria during early and aggressive antihypertensive treatment of insulin-dependent diabetic patients with diabetic nephropathy.
Parving HH; Andersen AR; Smidt UM; Friisberg B; Svendsen PA
Diabetes Care; 1981; 4(4):459-63. PubMed ID: 7049630
[TBL] [Abstract][Full Text] [Related]
19. Effect of the calcium channel blocker nilvadipine on urinary albumin excretion in hypertensive microalbuminuric patients with non-insulin-dependent diabetes mellitus.
Sumida Y; Yano Y; Murata K; Goto H; Ura H; Ezaki J; Tsutsumi S; Shirayama K; Misaki M; Shima T
J Int Med Res; 1997; 25(3):117-26. PubMed ID: 9178143
[TBL] [Abstract][Full Text] [Related]
20. Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy.
Andersen S; Jacobsen P; Tarnow L; Rossing P; Juhl TR; Parving HH
Nephrol Dial Transplant; 2003 Feb; 18(2):293-7. PubMed ID: 12543883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
